Everything Lupus: Resource Hub

Default Image

Honouring Dr. Murray B. Urowitz: A Legacy of Lupus Research

Read
Default Image

William Birchall Foundation gives $25,000 in support of Lupus Canada’s Scholarship Program

Read
Default Image

Anifrolumab (Saphnelo) listed in NS

Read
Default Image

The Canadian Immunocompromised Advocacy Network (CIAN) – Advocating For Immunocompromised People Across Canada

Read
Default Image

Lupus and COVID-19

Read
Default Image

Potential treatment for COVID-19 should not harm Canadians living with lupus

Read
Default Image

COVID-19 AND YOUR EMPLOYMENT RIGHTS

Read

Lupus Canada hosted a Facebook Live Q&A with Dr. Matsos on Tuesday, March 31. Dr. Matsos answered questions specific to COVID-19 and its impact on lupus.

Read
Default Image

The Canadian Rheumatology Association has released their position statement on COVID-19 and Hydroxychloroquine Supply

Read
Default Image

Canadian lupus patients missing critical drug after claims it treats coronavirus.

Read
Default Image

“Hydroxychloroquine has long been a standard treatment for lupus and rheumatoid arthritis patients.

Read